Press Releases

Trivitron Healthcare, a leading global medical technology company, proudly announces the launch of its state-of-the-art CT scanner, branded as “Terrene.” This ground-breaking technology is the first of its kind in India to receive approvals from the Bureau of Indian Standards (BIS), the Atomic Energy Regulatory Board (AERB) and Central Drugs Standard Control Organization (CDSCO), marking a significant milestone in the Indian healthcare industry. The aim of Terrene CT sca

Astria Health is proud to announce the ground breaking event for the Behavioral Health Unit expansion at Astria Toppenish Hospital (ATH). This expansion is a significant milestone in our commitment to mental health needs in the State of Washington. With strong support from legislators, community partners, local government and businesses, 100% of the required $13.1 million has been secured to complete the new unit. Since 2017, the Washington State Health Care Authority has been addressing the

Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it recently participated in a Virtual Investor “What This Means” segment. For the segment, Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discussed the current standard of care for people with

InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability and speed problems, today announced that

Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has achieved 100% pediatric patient enrollment at burn centers for its 2024 pivotal study designed to validate the AI-driven algorithm used by its DeepView™ System for its burn indication. This pivotal study is scheduled to be comp

Alpha Capital Anstalt, a prominent investor known for its successful ventures in the United States and globally, has finalized the acquisition of all operating assets and IP of ENvizion Medical Ltd., including ENvizion Medical Inc., based in Arlington Heights, Illinois, USA. Following this transaction, ENvizion Medical Inc. will operate as a privately held entity, independent from its former parent company, ENvizion Medical Ltd., which was previously publicly traded on the Tel Aviv

uniQure N.V., a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has entered into an agreement for the sale of its global manufacturing facility in Lexington, Massachusetts to Genezen, a leading contract development and manufacturing organization specializing in the supply of retroviral vectors, lentiviral vectors, and adeno-associated virus (AAV) technologies. Genezen agreed to acquire uniQure&rsquo

Artivion, Inc. a leading cardiac and vascular surgery company focused on aortic disease, today announced it has amended its credit facility and option purchase agreements with Endospan Ltd. ("Endospan"), an Israeli-based, privately-held developer of the NEXUS® Stent Graft System ("NEXUS"). In 2019, the Company provided a credit facility to Endospan and entered into an option agreement to purchase Endospan upon U.S. Food and Drug Administration ("FDA") ap

Not everything in the brain is meant to last. As our brains assemble, trillions of neural connections have to be built or torn down at the right time and place. Otherwise, the seeds of disorders like autism can take root. Cold Spring Harbor Laboratory Assistant Professor Gabrielle Pouchelon studies how the brain is wired early in life. In doing so, she hopes to find the origins of various brain dysfunctions and new ways to treat them. In a new study, Pouchelon and her team zero in o

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.